title: Is Interleukin-1 Receptor Blockade Ready for Prime Time in Patients With Severe Sepsis and Macrophage Activation Syndrome?
authors.affiliation: Division of Critical Care, Department of Anesthesiology, University of Nebraska Medical Center, Omaha, NE Division of Infectious Diseases, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE.
authors.forename: Daniel W
authors.initials: DW
authors.lastname: Johnson
authors.forename: Andre C
authors.initials: AC
authors.lastname: Kalil
mesh_terms: D004211:Disseminated Intravascular Coagulation / Q000453:epidemiology*; D005260:Female; D006801:Humans; D053590:Interleukin 1 Receptor Antagonist Protein / Q000627:therapeutic use*; D055501:Macrophage Activation Syndrome / Q000453:epidemiology*; D008297:Male; D017472:Receptors, Interleukin-1 / Q000037:antagonists & inhibitors*; D018805:Sepsis / Q000188:drug therapy* / Q000453:epidemiology*
chemical_list: D053590:Interleukin 1 Receptor Antagonist Protein; D017472:Receptors, Interleukin-1